183 related articles for article (PubMed ID: 29469177)
21. Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial.
Abril-Molina A; Gómez-Luque JM; Perin F; Esteban-Molina M; Ferreiro-Marzal A; Fernandez-Guerrero C; Ocete-Hita E
Drugs R D; 2021 Mar; 21(1):79-89. PubMed ID: 33367965
[TBL] [Abstract][Full Text] [Related]
22. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
Çavuşoğlu Y; Korkmaz Ş; Demirtaş S; Gencer E; Şaşmaz H; Mutlu F; Güneş H; Mert UK; Özdemir S; Kalaycı S; Yılmaz MB
Anatol J Cardiol; 2015 Aug; 15(8):611-7. PubMed ID: 26301344
[TBL] [Abstract][Full Text] [Related]
23. Levosimendan produces an additional clinical and hemodynamic benefit in patients with decompensated heart failure successfully submitted to a fluid removal treatment.
Giglioli C; Cecchi E; Landi D; Chiostri M; Spini V; Valente S; Gensini GF; Romano SM
Congest Heart Fail; 2012; 18(1):47-53. PubMed ID: 22277178
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
Sargento L; Brito D; Matias JS; Madeira H
Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581
[TBL] [Abstract][Full Text] [Related]
25. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
[TBL] [Abstract][Full Text] [Related]
26. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial.
Pölzl G; Altenberger J; Comín-Colet J; Delgado JF; Fedele F; García-González MJ; Gustafsson F; Masip J; Papp Z; Störk S; Ulmer H; Maier S; Vrtovec B; Wikström G; Zima E; Bauer A;
Eur J Heart Fail; 2023 Nov; 25(11):2007-2017. PubMed ID: 37634941
[TBL] [Abstract][Full Text] [Related]
27. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden.
Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study.
García-González MJ; Aldea Perona A; Lara Padron A; Morales Rull JL; Martínez-Sellés M; de Mora Martin M; López Díaz J; López Fernandez S; Ortiz Oficialdegui P; Jiménez Sosa A
ESC Heart Fail; 2021 Dec; 8(6):4820-4831. PubMed ID: 34716753
[TBL] [Abstract][Full Text] [Related]
29. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
[TBL] [Abstract][Full Text] [Related]
30. Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.
Zhang D; Yao Y; Qian J; Huang J
Med Sci Monit; 2015 Aug; 21():2439-45. PubMed ID: 26289557
[TBL] [Abstract][Full Text] [Related]
31. Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.
Tasal A; Demir M; Kanadasi M; Bacaksiz A; Vatankulu MA; Sahin DY; Eker RA; Bozkurt A; Acarturk E
Med Sci Monit; 2014 Feb; 20():276-82. PubMed ID: 24549281
[TBL] [Abstract][Full Text] [Related]
32. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S
Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L;
Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653
[TBL] [Abstract][Full Text] [Related]
34. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
Cui D; Liao Y; Li G; Chen Y
Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
Udvary E; Papp JG; Végh A
Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
[TBL] [Abstract][Full Text] [Related]
36. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
Paksoy F; Ulaş T; Tursun I; Dal MS; Oztekin E; Borlu F
Anadolu Kardiyol Derg; 2012 Feb; 12(1):16-22. PubMed ID: 22214738
[TBL] [Abstract][Full Text] [Related]
37. Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
Büyüklü M; Kürüm AT; Tatlý E; Set T
Arq Bras Cardiol; 2012 Jul; 99(1):659-64. PubMed ID: 22735864
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure.
Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ
Int J Clin Pharmacol Ther; 2002 Oct; 40(10):465-71. PubMed ID: 12395979
[TBL] [Abstract][Full Text] [Related]
39. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
Cleland JG; Nikitin N; McGowan J
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms.
Fedele F; Bruno N; Brasolin B; Caira C; D'Ambrosi A; Mancone M
Eur J Heart Fail; 2014 Mar; 16(3):281-8. PubMed ID: 24464960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
